Epitalon: Telomeres, Sleep and the Anti-Aging Flagship

Epitalon (also spelled Epithalon) is a small lab-made peptide that copies a natural one from the pineal gland. That is a pea-sized gland deep in your brain. It makes melatonin, the hormone that makes you sleepy at night and keeps your body clock on time. As you get older it makes less. Sleep tends to get lighter, and your body clock gets weaker.

So in plain terms, Epitalon aims at two things. The first is your body clock: helping an ageing pineal gland get back to a normal night-time melatonin rhythm, so sleep comes more easily and runs deeper. The second is ageing at the level of your cells, through the telomere effect seen in the lab.

The honest version is this. The sleep side is the part you can feel, and the part with the firmest human research behind it. The telomere side is the bigger promise, and it is why Epitalon is the best-known "anti-aging peptide". But it is still a lab and animal story. Nobody has shown it makes a person live longer.

This guide starts with what a course is actually like. It then covers what Epitalon is, the telomere research, sleep, and skin and general anti-aging. Last, it covers dosing and where its legal status sits in 2026.

What does Epitalon actually do for you?

Here is what to expect from a course, in everyday terms.

• Better sleep. This is the effect people notice most. Users commonly report deeper sleep and vivid dreams. In the research on older people, the night-time melatonin pattern was reported to return to normal within about the first week.
• Feeling better in yourself. Another common user report is a lift in general wellbeing and energy. It tends to show up in the weeks after a course ends, rather than during it.
• Skin and hair. Some users report better skin and hair. This comes only from user reports. No controlled study has measured it.
• The long game. The telomere and lifespan side is the reason most people take it. You will not feel it, and it is not proven in people. You are backing a strong lab result, not buying a guaranteed one.

What not to expect: a rush, a buzz, or anything you feel on the day you inject. It does not change strength or body shape either. That is not what the research describes.

A few things can go the other way. Taken close to bedtime, some people report restless nights or feeling wired, which is why most take it in the morning. Others report some daytime drowsiness, or mild irritation where they inject. These are occasional user reports, and usually mild.

Epitalon is a lab-made peptide, four amino acids long (AEDG). In longevity research it is the closest thing there is to a flagship. When someone says "the telomere peptide," this is the one they mean. Unlike many compounds with that kind of promise, it has a real mechanism and a quarter-century of research behind it. Most of that research comes from one Russian group, and much of it is older. We cover what that means further down.

What is Epitalon?

Epitalon is a synthetic tetrapeptide, meaning four amino acids joined in a chain. The four are alanine, glutamate, aspartate and glycine, which is where its other name, AEDG, comes from. It is a lab-made copy of a piece of Epithalamin. Epithalamin is a natural peptide mix taken from the pineal gland. That is a small structure deep in the brain. It controls melatonin, the hormone that makes you sleepy at night, and the day-night clock.

That pineal origin is the whole point. The thinking behind Epitalon comes from a Russian school of "peptide bioregulators". Vladimir Khavinson developed it over several decades. The idea is that short peptides taken from a given organ act as signals for that organ. They are proposed to help it work like a younger version of itself.

In animal models, the pineal gland is one of the first systems to slow down with age. Melatonin output drops, sleep gets shallower, and the body clock gets weaker. Epitalon is studied as a signal that may turn some of that back up. In lab work it has also been reported to switch on genes while new nerve cells form (Khavinson 2020, Molecules). Whatever you make of the theory, it explains the two best-studied effects. They are the ones you would expect: telomere upkeep in cells, and a restored body clock in older animals.

One practical note before going further. Epitalon is a peptide, so the gut would digest it like food. That is why it is given as a subcutaneous injection, a small injection into the fat just under the skin. Some vendors sell oral or sublingual (under the tongue) versions, and nasal sprays. But no one has shown that enough of the compound reaches the bloodstream that way. The view on the injection forums is under-the-skin only. New to mixing and injecting? See how to reconstitute and dose.

Does Epitalon actually lengthen telomeres?

In cell studies, yes. Epitalon has been reported to switch on telomerase and lengthen telomeres in human cells grown in the lab. Khavinson's group showed it first (Khavinson 2003, Bull Exp Biol Med). In 2025, an independent group at Brunel University London repeated the result (Al-Dulaimi 2025, Biogerontology). These results are in vitro, meaning in cells in a dish. Testing in living people is the next step, and we cover where that stands below.

How it works. Telomeres are protective caps on the ends of your chromosomes, the bundles of DNA packed inside every cell. Each time a cell divides, they get a little shorter. When they run down too far, the cell stops dividing and ages. Telomerase is the enzyme that can rebuild them. Most adult cells keep it mostly switched off. The big claim is that Epitalon turns it back on. The first evidence came from Khavinson's group in 2003. They reported that it raised telomerase activity and made telomeres longer in human cells grown in the lab (Khavinson 2003, Bull Exp Biol Med).

Why 2025 matters. For most of its history, that finding came almost entirely from the Khavinson group. Then last year an independent group at Brunel University London repeated the core result. They found that telomeres got longer in normal human cells, through telomerase, and more so at higher doses (Al-Dulaimi 2025, Biogerontology). It is the first major independent Western confirmation of the main lab claim, and it makes the case stronger.

Animal lifespan. The animal data is consistent, and it comes from the same research group. Epitalon raised maximum lifespan by roughly +12 to 13% in one strain of mouse (Anisimov 2003). In fruit flies the figure was +11 to 16% (Khavinson 2000). These are modest but encouraging signs.

So the telomere story has a real cell mechanism, now repeated by a second lab. It also has decades of consistent animal data. The missing piece is proof in people. That still puts it in a stronger spot than most longevity compounds.

What does the research say about Epitalon and sleep?

The best-studied effect of Epitalon is on the melatonin rhythm, which sets the timing of sleep. Khavinson's group studied older people whose pineal output had faded. They reported that the related pineal peptide brought back the normal night-time melatonin rhythm (Korkushko 2004, Bull Exp Biol Med; Korkushko 2007, Adv Gerontol). Outside the cell work on telomeres, this is its firmest ground. It is why the pineal gland and melatonin are its signature research area.

Bringing back night-time melatonin is the result the pineal research reports most often. The melatonin rhythm is the same system that controls when you sleep. The first trials were in older people whose melatonin was already low. So the results apply to a low-melatonin starting point. They should not be read across to a young person with a healthy rhythm. The size of the effect will not carry over to other groups.

On timing, reports vary on how well it is tolerated around bedtime. Morning use is the common choice among users. Treat timing as something to keep steady during a research course.

This body-clock angle is also what sets it apart from the rest of the longevity shelf:

• NAD+, a coenzyme cells use to turn food into usable energy, works on cell energy.
• MOTS-c works on metabolic signalling.
• SS-31 works on protecting the membrane of the mitochondria, the tiny power plants inside every cell.

None of them touch the pineal gland and melatonin. That is the area it owns in the research. It is why it sits well inside the wider longevity peptide stacks rather than overlapping with them.

What is the evidence for Epitalon and skin or general anti-aging?

In the lab, Epitalon acts as an antioxidant and protects mitochondria. Antioxidants are molecules that clear up harmful waste made by cells, before it does damage. This was shown in a model of ageing mouse egg cells (Yue 2022, Aging). That is the documented thread people extend to skin and tissue quality. The idea makes sense, but it has not been measured. There is no controlled study yet on skin, hair or nails.

So the "anti-aging tune-up" idea rests on a lab mechanism plus community reports, not on trial results. For a direct skin mechanism, GHK-Cu has stronger published evidence. That is why the two are often discussed together. It works on the whole body rather than targeting skin.

There is also a small thread on thinking and longevity. One published case report described a Semax-and-Epitalon protocol in one patient. It reported changes in thinking scores and in epigenetic age (Berman & Berman 2024, J Restorative Medicine). Epigenetic age is a lab estimate of how old your cells are, rather than your birthday age. There was no control group, so it is a starting point for ideas, nothing more. If the brain side interests you, the brain peptides guide covers it properly.

What does the human evidence on Epitalon actually say?

This is the main thing to understand before you start. The human evidence is thin, dated and mostly uncontrolled, and there is no modern registered trial.

All the telomere results so far are in cells. No controlled study has measured telomere length in a living person before and after an Epitalon course and shown it rise. Lengthening telomeres in a dish is one thing. Lengthening a person's telomeres and extending life is another, and that step has not been made in humans yet.

There is no Phase 1, 2 or 3 trial of Epitalon on ClinicalTrials.gov. The "human trials" you will see cited are older Russian-language studies. Many used the parent extract, Epithalamin, rather than the pure lab-made peptide. Most lack a placebo group, blinding and statistics planned in advance, which a modern Western trial needs.

• No registered modern trials. Nothing is listed on ClinicalTrials.gov, and the Russian work cited comes from before modern trial standards.
• The strongest long-term human signal used the parent extract. A 15-year follow-up of older heart patients reported significantly lower death rates from all causes in the treated group. Their melatonin rhythm was also preserved (Korkushko 2011, Bull Exp Biol Med). That is striking. But it was a small study (79 subjects), and it used Epithalamin, the parent extract, not Epitalon itself. So it is supporting context, not direct proof for the peptide.
• An open-label eye study. A larger series looked at people with retinitis pigmentosa, an inherited eye disease. It reported changes in how sharply and how widely they could see (Khavinson 2002, Neuroendocrinol Lett, n=162). Open-label means everyone knew they were getting the treatment, and there was no control group. So it cannot rule out placebo or natural ups and downs. A 2025 overview (Araj 2025, Int J Mol Sci) lists these same limits across the research.

In short, it has a strong cell mechanism, now repeated by an independent lab. It has consistent animal data from one group. And it has a thin, dated human layer with no modern RCT. An RCT, or randomised controlled trial, is the gold standard in medicine for proving something works. Decades of use and a real mechanism put it well ahead of most longevity compounds. The missing human proof keeps it short of "established". Both are true at once.

What is the cancer concern with Epitalon?

The concern is in theory only, and still open. The animal data points the other way. Epitalon switches on telomerase, and cancer cells use that same machinery to keep dividing forever. That is the worry on paper. But the rodent work from Khavinson and Anisimov found fewer and smaller tumours, not more. This was in a HER-2/neu breast tumour model (Anisimov 2002, Int J Cancer). So the signal in living animals so far is reassuring. The open question sits at the cell level.

The 2025 Brunel study added a wrinkle. In breast-cancer cell lines, Epitalon lengthened telomeres through a different backup pathway called ALT (Al-Dulaimi 2025). That is a flag, not a verdict. For context, ALT is the upkeep pathway in only around 3.7% of primary tumours (Heaphy 2011, Am J Pathol). That is far below the 10 to 15% figure that goes around peptide forums.

In practice, the rodent data is reassuring, but the ALT finding in cell lines keeps the cancer question open. You may have an active cancer, a recent one, or a strong family history (especially of hormone-sensitive cancers). If so, take this question to a qualified doctor. It is not something to settle from a guide.

How is Epitalon dosed and cycled in research protocols?

Epitalon is used in courses, not as a daily supplement forever. Russian clinics and users land on the same short block. That is roughly 5 to 10 mg per day, under the skin, for 10 to 20 days in a row, repeated once or twice a year. The protocols describe effects that carry on for weeks to months after the block ends. That is why it is cycled rather than taken every day.

The common pattern comes from the Khavinson protocols, and users copy it:

• Standard course: roughly 5 to 10 mg per day, under the skin, for 10 to 20 days in a row, repeated once or twice a year. This is the classic "anti-aging course" in the literature.
• Timing: many protocols run it in autumn or winter. Morning use is the more practical tip, to avoid the bedtime issues mentioned above.

Here is a worked example to make the numbers concrete. Mix a 50 mg vial with 2 mL of BAC water to get 25 mg/mL. A 10 mg daily dose is then 0.4 mL. On a U-100 insulin syringe, that is the 40-unit mark. A 5 mg dose is 0.2 mL, the 20-unit mark. So a 50 mg vial at 10 mg/day covers a 5-day stretch of a course. A single 10 to 20 day block at the top of the range needs two to four 50 mg vials.

There is an open debate worth flagging. The first Russian "10 mg" doses were based on Epithalamin, the parent extract. Some in the community argue the extract is much weaker than the pure lab-made peptide. If they are right, 10 mg a day of pure peptide may be well above the first signal. Something closer to 1 mg a day might match it. No study has compared the two. So this stays a disputed view among users, not a settled dose. We flag it because it is a real disagreement, not because there is a clean answer.

On stacking, Epitalon fits into a longevity rotation rather than competing with it. Common pairings among users are:

• Epitalon with NAD+ (telomeres plus cell energy).
• Epitalon with GHK-Cu (telomeres and body clock, plus skin and collagen research).
• Epitalon in the classic Khavinson bioregulator plan, alongside thymus peptides.

None of these pairings are proven in trials. They are user protocols that make sense given how each compound works, and they are best seen that way. The longevity peptide stacks guide shows how these fit together.

How do you reconstitute and store Epitalon?

Mix it with bacteriostatic (BAC) water, keep it in the fridge, and keep it dark. The usual rules for freeze-dried peptides apply. (Lyophilised just means freeze-dried into a stable powder.)

Add bacteriostatic (BAC) water. This is water with a small amount of preservative. It stops bacteria growing in the vial over the days you draw from it. Never use sterile or plain water. They have no preservative and are only safe for a single use. Store the mixed vial in the fridge at 2 to 8 degrees, and keep it out of the light. Do not freeze the mixed solution, and swirl rather than shake. The full walkthrough is in how to reconstitute and dose.

Two quirks are specific to Epitalon:

• Some vials come as the acetate salt at low pH (slightly acidic). At higher strengths, such as a 50 mg vial, people report needing more BAC water, around 3 mL, to get a fully clear solution. At 3 mL, a 50 mg vial works out to 16.7 mg/mL. A 10 mg dose is then 0.6 mL (60 units on a U-100 syringe).
• Epitalon is not usually mixed with GHK-Cu in the same vial. If you use both, keep them in separate vials and draw them separately.

A note on route, since clinics elsewhere sometimes do it differently. Russian protocols have used shots into the muscle, and even nasal use, and you may read about those. For research and community use, and for Primogen's purposes, the standard is subcutaneous (under the skin). Primogen does not recommend any intravenous use (into a vein).

Is Epitalon legal, and is it banned in sport?

Epitalon is a research compound, not an approved drug. For tested athletes, it should be treated as banned. Its status has shifted recently. Here is the current picture.

• United States: It is not an approved drug. On 29 September 2023, the FDA put Epitalon on a restricted compounding list (Interim 503A Bulks List, Category 2). It cited possible immunogenicity, meaning the risk of an unwanted immune reaction, from clumping and peptide impurities. It also cited a lack of safety data (FDA 503A bulk substances list). That detail is often mixed up in summaries. The FDA cited a lack of information, not proven harm. As of the FDA's April 2026 update, those nominations had been withdrawn. A compounding advisory committee review was set for July 2026. The net effect: US compounding pharmacies have not been able to make Epitalon since late 2023.
• Russia: The parent extract, Epithalamin, has long been registered there. It has been used in Russian ageing clinics for decades, as part of the wider bioregulator approach. That long history, without reports of severe side effects, is part of why the safety picture is reassuring. That holds even while the formal Western data is thin.
• Anti-doping: Epitalon is not named on the WADA list. But no government regulator has approved it for human use, so it falls under the "non-approved substances" category. That means it should be treated as banned in tested sport (WADA 2026). If you are a drug-tested athlete, leave it alone.

Referenced products

Epitalon

Rp 2.590.000 · 50mg

NAD+

from Rp 1.290.000

GHK-Cu

from Rp 990.000

MOTS-c

Rp 2.390.000 · 40mg

SS-31

Rp 4.290.000 · 50mg

Who is Epitalon for, and who should skip it?

It suits the longevity and biohacker crowd who want the telomere and body-clock research angle. They know they are buying a promising mechanism, not a proven result in people. Its best research sits on the pineal gland and melatonin, so it tends to appeal to people interested in that area. It also suits anyone running a once- or twice-yearly research course as part of a wider longevity rotation, alongside NAD+ and the rest.

It is a poor fit if you want a daily compound with an effect you can feel day to day. This is a course you run and then mostly set aside. It is also a poor fit for anyone with a cancer history or strong family risk, until a doctor has cleared it. And it is off-limits for a tested athlete. No peptide can promise a longer life. Its appeal is the strength of its mechanism and its long research record, not a proven number on the scoreboard.